{
    "question": "Do nonhuman primates produce neutralizing antibodies after immunization with EILV/CHIKV generated in mosquito cells? Answer with Yes or No.",
    "content": {
        "source_1": "In nonhuman primates, EILV/CHIKV elicited rapid and robust immunity that protected against viremia and telemetrically monitored fever.",
        "source_2": "A single dose of mosquito cellâ€“derived EILV/CHIKV failed to generate neutralizing antibodies in nonhuman primates over a 120-day follow-up and did not prevent viremia upon challenge.",
        "source_3": "A single immunization with EILV/CHIKV propagated in mosquito cells induced neutralizing antibodies within four days that persisted for more than 290 days, conferring complete protection in two distinct mouse models.",
        "source_4": "In macaques, post-vaccination sera contained only binding, non-neutralizing antibodies and telemetry recorded persistent febrile episodes, indicating no protective immunity against viremia following EILV/CHIKV exposure."
    },
    "answer": "Not reported",
    "accuracy_labels": [
        true,
        false,
        true,
        false
    ]
}